ArticleFrontiers in pharmacology2025

Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPARγ signaling pathway and gut microbiota in mice.

Jiuchen Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.